Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions
Introduction: Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez)
Myelodysplastic Syndromes (MDS)
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
The WHO and International Consensus Classification 2022 classifications of myelodysplastic syndromes myelodysplastic syndromes:
MDS Virtual Support Group - Saturdays - 2025 July
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with MDS. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants.
Aplastic Anemia, MDS, PNH Virtual Support Group-Saturdays-2026 February
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious co
Hassan Alkhateeb, MD
Institution
Mayo Clinic - Rochester
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
Alejandro Marinos Velarde, MD
Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
About
Alejandro Marinos Velarde, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in allogeneic stem cell transplant and acute myeloid leukemia. Dr. Marinos Velarde earned his medical degree at the Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia in Lima, Peru. He completed a residency in internal medicine at Beaumont Hospital in Royal Oak, Michigan; a fellowship in hematology and oncology at the Baylor College of Medicine in Houston; and a fellowship in stem cell transplant and cellular therapy at MD
Afaf Osman, MD
Institution
University of Utah School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Panel Discussion: The Spectrum of Supportive Care for Bone Marrow Failure Patients
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Marlys Medina, MSW
Manuel Espinoza Gutarra, MD
Ingrid Gabriela Barrera, PsyD
This symposium session explores the multidisciplinary approach to patient care, featuring insights from a social worker, a physician, and a psychiatrist. The video highlights the emotional, physical, and mental health challenges faced by patients with bone marrow failure and the…
Panel Discussion: Making Clinical Trial Participation Diverse and Accessible
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presenter(s)
Shaalan Beg, MD, MBA, FASCO
Maria Velez, MD, MS
Ashley Woods, MD
This symposium session highlights key strategies for fostering inclusivity in clinical research. Presentations cover the benefits and challenges of decentralized clinical trials, the critical role of translating consent documents for patients with limited English proficiency, and…